Cargando…

The Capacity of Magnesium to Induce Osteoclast Differentiation Is Greatly Enhanced by the Presence of Zoledronate

SIMPLE SUMMARY: A number of skeletal disorders, all characterized by a metabolic or neoplastic loss of bone tissue, are cured with drugs called Bisphosphonates (BPs), which exert their therapeutic effect by suppressing cells named osteoclasts, normally mediating bone resorption. Unfortunately, these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricchiuto, Silvia, Palumbo, Rossella, Lami, Francesca, Gavioli, Francesca, Caselli, Lorenzo, Montanari, Monica, Zappavigna, Vincenzo, Anesi, Alexandre, Zanocco-Marani, Tommaso, Grande, Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604702/ https://www.ncbi.nlm.nih.gov/pubmed/37887007 http://dx.doi.org/10.3390/biology12101297

Ejemplares similares

Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D(3)
por: Mammoli, Fabiana, et al.
Publicado: (2019)

From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights
por: Anesi, Alexandre, et al.
Publicado: (2019)

Wnt/CTNNB1 Signal Transduction Pathway Inhibits the Expression of ZFP36 in Squamous Cell Carcinoma, by Inducing Transcriptional Repressors SNAI1, SLUG and TWIST
por: Zanfi, Emma D., et al.
Publicado: (2020)

ZFP36L1 Negatively Regulates Erythroid Differentiation of CD34+ Hematopoietic Stem Cells by Interfering with the Stat5b Pathway
por: Vignudelli, Tatiana, et al.
Publicado: (2010)

How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022)

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro
por: Li, Pengfei, et al.
Publicado: (2018)

Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of “Giant Osteoclasts” and Pathogenetic Implications
por: Corsi, Alessandro, et al.
Publicado: (2020)

Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals
por: Møller, Anaïs M J, et al.
Publicado: (2020)

Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells
por: Tai, Ta-Wei, et al.
Publicado: (2017)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
por: Kim, Hyung Joon, et al.
Publicado: (2019)

Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB
por: Gao, Si-yong, et al.
Publicado: (2017)

Promoter Methylation Leads to Decreased ZFP36 Expression and Deregulated NLRP3 Inflammasome Activation in Psoriatic Fibroblasts
por: Bertesi, Matteo, et al.
Publicado: (2021)

ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly
por: Selmi, Tommaso, et al.
Publicado: (2015)

Inhibition Effect of Zoledronate on the Osteoclast Differentiation of RAW264.7 Induced by Titanium Particles
por: Zhao, Wenhan, et al.
Publicado: (2021)

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
por: Kong, Sung Hye, et al.
Publicado: (2022)

Facile fabrication of the zoledronate-incorporated coating on magnesium alloy for orthopaedic implants
por: Chen, Shanshan, et al.
Publicado: (2019)

Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice
por: Vegger, Jens Bay, et al.
Publicado: (2018)

Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
por: Wang, Lianwei, et al.
Publicado: (2020)

A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification in the DNA methylome
por: Tan, Qihua, et al.
Publicado: (2023)

Regulation of osteogenesis and osteoclastogenesis by zoledronic acid loaded on biodegradable magnesium-strontium alloy
por: Li, Mei, et al.
Publicado: (2019)

In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2022)

Zoledronic acid promotes osteoclasts ferroptosis by inhibiting FBXO9-mediated p53 ubiquitination and degradation
por: Qu, Xingzhou, et al.
Publicado: (2021)

Loss of zfp36 expression in colorectal cancer correlates to wnt/ β-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1
por: Montorsi, Lucia, et al.
Publicado: (2016)

Magnesium vs. machined surfaced titanium - osteoblast and osteoclast differentiation
por: Kwon, Yong-Dae, et al.
Publicado: (2014)

Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways
por: Huang, Xiao-Lin, et al.
Publicado: (2019)

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
por: Lotti, Roberta, et al.
Publicado: (2023)

Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid
por: Porru, Manuela, et al.
Publicado: (2014)

Osteoclast and osteoblast responsive carbonate apatite coatings for biodegradable magnesium alloys
por: Hiromoto, Sachiko, et al.
Publicado: (2020)

Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use
por: Abate, Marianna, et al.
Publicado: (2022)

Chitosan-Based Polyelectrolyte Complexes for Doxorubicin and Zoledronic Acid Combined Therapy to Overcome Multidrug Resistance
por: Giarra, Simona, et al.
Publicado: (2018)

Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2019)

Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes
por: Montorsi, L, et al.
Publicado: (2016)

Rosehip Extract-Functionalized Magnesium Hydroxide Nanoparticles and Its Effect on Osteoblastic and Osteoclastic Cells
por: Pinho, Laura Costa, et al.
Publicado: (2021)

Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment
por: Kameda, Yuka, et al.
Publicado: (2021)

Eldecalcitol effects on osteoblastic differentiation and function in the presence or absence of osteoclastic bone resorption
por: Bu, Jie, et al.
Publicado: (2019)

Depletion of Trichoplein (TpMs) Causes Chromosome Mis-Segregation, DNA Damage and Chromosome Instability in Cancer Cells
por: Lauriola, Angela, et al.
Publicado: (2020)

Endometrial Cancer Diagnosed by the Presence of Bone Metastasis and Treated with Zoledronic Acid: A Case Report and Review of the Literature
por: Shigemitsu, Aiko, et al.
Publicado: (2010)

High Magnesium Corrosion Rate has an Effect on Osteoclast and Mesenchymal Stem Cell Role During Bone Remodelling
por: Maradze, Diana, et al.
Publicado: (2018)

3D-printed biodegradable magnesium alloy scaffolds with zoledronic acid-loaded ceramic composite coating promote osteoporotic bone defect repair
por: Ran, Zhaoyang, et al.
Publicado: (2023)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_03hmv6odaaf13is3ji0bhcg46c